Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

US Government cuts to mRNA vaccine research could set technological advances, reduce access to therapies, and raise their ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...